Triple negative breast cancer (TNBC) is defined as the absence of tumor tissue expression of the estrogen receptor (ER), progesterone receptor (PR) and the human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ESR1 and neoplasm.